<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03492983</url>
  </required_header>
  <id_info>
    <org_study_id>GRS 1583/B/17</org_study_id>
    <nct_id>NCT03492983</nct_id>
  </id_info>
  <brief_title>Effect of High Cocoa Content Chocolate on Health in Postmenopausal Women.</brief_title>
  <official_title>Effect of High Cocoa Content Chocolate on Vascular Function, Body Composition, Health-related Quality of Life and Cognitive Performance in Postmenopausal Women.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Castilla-Le√≥n Health Service</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Investigacion y Formacion en Ciencias de la Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical trial aimed at postmenopausal women aged 50 to 64 years old
      selected in urban primary care centers of two centers (Spain). Its objective is to evaluate
      the effects of the additional intake of high cocoa content chocolate on blood pressure,
      vascular function, body composition, quality of life and cognitive performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Objective: To assess the effect at 6 months of the additional intake of 10 g/day of high
           cocoa content chocolate for 6 months on blood pressure, vascular function, body
           composition, quality of life and cognitive performance in postmenopausal women.

        -  Design and setting: A randomized clinical trial of two parallel groups. Population: 140
           postmenopausal women, 50 to 64 aged will be included, selected by consecutive sampling
           in two primary care centers.

        -  Measurements and intervention: Vascular function (blood pressure, augmentation index and
           Cardio-Ankle Vascular Index), body composition and health-related quality of life will
           be evaluated. The intervention group will receive a daily supplement of high cocoa
           content chocolate for 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by oscillometric method (mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial stiffness</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by Brachial-ankle pulse wave velocity (m/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wave reflection</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by central and peripheral augmentation index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by body fat percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by Cervantes Scale (Score between 0 (poor quality) and 155 (high quality)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement by executive function</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Postmenopausal Women</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Addition of 10 g/day of high cocoa content chocolate to the usual diet for six months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Intervention group</intervention_name>
    <description>10 g/day of high cocoa content chocolate for six months.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women in postmenopausal period defined as 12 consecutive months of amenorrhea.

        Exclusion Criteria:

          -  Older than 65 years.

          -  Cardiovascular disease (acute myocardial infarction, stroke).

          -  Arterial hypertension on treatment.

          -  Diabetes mellitus.

          -  Dyslipidemia (total cholesterol &gt;250 mg/dL or in lipid-lowering therapy).

          -  Clinically demonstrable neurological and/or neuropsychological disorders.

          -  Hormone replacement therapy.

          -  Allergy and/or intolerance to cocoa or any of the components of the supplement.

          -  Hypocaloric diet.

          -  Any other circumstance that the investigators consider could interfere with the study
             procedures.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose I Recio-Rodriguez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Salamanca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose I Recio-Rodriguez, PhD</last_name>
    <phone>923231859</phone>
    <email>donrecio@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto Biosanitario de Salamanca. Research unit La Alamedilla</name>
      <address>
        <city>Salamanca</city>
        <zip>37003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose I Recio-Rodriguez, Coordinator</last_name>
      <phone>923231859</phone>
      <phone_ext>53550</phone_ext>
      <email>donrecio@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Luis Garcia Ortiz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose A Maderuelo-Fernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosario Alonso-Dominguez, Nurse</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natalia Sanchez-Aguadero, Nurse</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irene A Garcia-Yu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Martin-Martin, Nurse</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesus Gonzalez-Sanchez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara P Mora-Simon, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susana Gonzalez-Manzano, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esmeralda Gomez-Miguel, Nurse</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2018</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cocoa</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Body composition</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Cognitive performance</keyword>
  <keyword>Postmenopausal women</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

